RSS feed

Publications by Ole Rasmus Ødegaard

61 publications found

Original articles

Flengsrud R, Larsen ML, Ødegaard OR (2010)
Purification, characterization and in vivo studies of salmon heparin
Thromb Res, 126 (6), e409-17
DOI 10.1016/j.thromres.2010.07.004, PubMed 20937523

Reinton N, Ødegaard OR, Helgheim A, Moghaddam A (2007)
[Detection of Chlamydia infection of an Internet-based commercial product]
Tidsskr Nor Laegeforen, 127 (16), 2080-2
PubMed 17717570

Trydal T, Bolann B, Brosstad F, Sandberg S, Sandset PM, Stavelin A, Steensland H, Thue G, Ødegaard OR (2005)
[Analysis of prothrombin time in primary health care]
Tidsskr Nor Laegeforen, 125 (15), 2048-9
PubMed 16100552

Lindahl TL, Egberg N, Hillarp A, Ødegaard OR, Edlund B, Svensson J, Sandset PM, Rånby M (2004)
INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples
Thromb Haemost, 91 (6), 1223-31
DOI 10.1160/TH03-07-0456, PubMed 15175811

Andresen MS, Abildgaard U, Liestøl S, Sandset PM, Mowinckel MC, Ødegaard OR, Larsen ML, Diep LM (2004)
The ability of three global plasma assays to recognize thrombophilia
Thromb Res, 113 (6), 411-7
DOI 10.1016/j.thromres.2004.05.002, PubMed 15226097

Dahl T, Kontny F, Slagsvold CE, Christophersen B, Abildgaard U, Odegaard OR, Morkrid L, Dale J (2000)
Lipoprotein(a), other lipoproteins and hemostatic profiles in patients with ischemic stroke: the relation to cardiogenic embolism
Cerebrovasc Dis, 10 (2), 110-7
DOI 10.1159/000016039, PubMed 10686449

Salte R, Norberg K, Odegaard OR (1996)
Evidence of a protein C-like anticoagulant system in bony fish
Thromb Res, 83 (5), 389-97
DOI 10.1016/0049-3848(96)00148-x, PubMed 8873347

Salte R, Norberg K, Odegaard OR (1995)
Some functional properties of teleost antithrombin
Thromb Res, 80 (3), 193-200
DOI 10.1016/0049-3848(95)00167-p, PubMed 8578545

Dahlberg M, Odegaard OR, Try K, Amundsen T (1995)
An automated C4b binding protein assay compared with an electroimmunoassay in a clinical material
Scand J Clin Lab Invest, 55 (2), 133-7
DOI 10.3109/00365519509089605, PubMed 7667606

Aadland E, Odegaard OR, Røseth A, Try K (1994)
Free protein S deficiency in patients with Crohn's disease
Scand J Gastroenterol, 29 (4), 333-5
DOI 10.3109/00365529409094844, PubMed 8047807

Gerdts R, Gundersen T, Odegaard OR (1993)
[Familial protein S deficiency]
Tidsskr Nor Laegeforen, 113 (28), 3464-5
PubMed 8273076

Odegaard OR, Try K, Ly B, Gundersen T, Linnebo S (1993)
[Protein S deficiency, acute phase reaction and thrombosis]
Tidsskr Nor Laegeforen, 113 (28), 3460-3
PubMed 7505957

Aadland E, Odegaard OR, Røseth A, Try K (1992)
Free protein S deficiency in patients with chronic inflammatory bowel disease
Scand J Gastroenterol, 27 (11), 957-60
DOI 10.3109/00365529209000170, PubMed 1455194

Lindahl AK, Odegaard OR, Sandset PM, Harbitz TB (1992)
Coagulation inhibition and activation in pancreatic cancer. Changes during progress of disease
Cancer, 70 (8), 2067-72
DOI 10.1002/1097-0142(19921015)70:8<2067::aid-cncr2820700809>3.0.co;2-a, PubMed 1394036

Odegaard OR, Lindahl AK, Try K, Kvalheim G, Sørbø JH (1992)
Recurrent venous thrombosis during warfarin treatment related to acquired protein S deficiency
Thromb Res, 66 (6), 729-34
DOI 10.1016/0049-3848(92)90048-f, PubMed 1519231

Bell H, Odegaard OR, Andersson T, Raknerud N (1992)
Protein C in patients with alcoholic cirrhosis and other liver diseases
J Hepatol, 14 (2-3), 163-7
DOI 10.1016/0168-8278(92)90153-g, PubMed 1500680

Sandset PM, Larsen ML, Abildgaard U, Lindahl AK, Odegaard OR (1991)
Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol
Blood Coagul Fibrinolysis, 2 (3), 425-33
DOI 10.1097/00001721-199106000-00004, PubMed 1932528

Gundersen T, Gjennestad AL, Odegaard OR (1991)
[Protein C deficiency and the P pill]
Tidsskr Nor Laegeforen, 111 (10), 1245-6
PubMed 2042136

Odegaard OR (1991)
The long-term safety of antihyperlipidaemic drugs
Int J Risk Saf Med, 2 (4), 197-201
DOI 10.3233/JRS-1991-2404, PubMed 23511916

Abildgaard U, Norrheim L, Larsen AE, Nesvold A, Sandset PM, Odegaard OR (1990)
Monitoring therapy with LMW heparin: a comparison of three chromogenic substrate assays and the Heptest clotting assay
Haemostasis, 20 (4), 193-203
DOI 10.1159/000216127, PubMed 2173672

Aksnes L, Rödland O, Odegaard OR, Bakke KJ, Aarskog D (1989)
Serum levels of vitamin D metabolites in the elderly
Acta Endocrinol (Copenh), 121 (1), 27-33
DOI 10.1530/acta.0.1210027, PubMed 2787088

Eide D, Odegaard OR (1989)
[Familial antithrombin deficiency]
Tidsskr Nor Laegeforen, 109 (7-8), 836-7
PubMed 2705167

Abildgaard U, Sandset PM, Andersson TR, Odegaard OR, Rosĕn S (1988)
The inhibitor of F VIIa in plasma measured with a sensitive chromogenic substrate assay: comparison with antithrombin, protein C and heparin cofactor II in a clinical material
Folia Haematol Int Mag Klin Morphol Blutforsch, 115 (3), 274-7
PubMed 2465215

Andersson TR, Berner NS, Larsen ML, Odegaard OR, Abildgaard U (1987)
Plasma heparin cofactor II, protein C and antithrombin in elective surgery
Acta Chir Scand, 153 (4), 291-6
PubMed 3630527

Lamvik J, Odegaard OR, Abildgaard U (1987)
[Protein C deficiency. A possible cause of fetal death and recurrent venous thrombosis]
Tidsskr Nor Laegeforen, 107 (8), 739-40
PubMed 3576571

Odegaard OR, Try K, Andersson TR (1987)
Protein C: an automated activity assay
Haemostasis, 17 (3), 109-13
DOI 10.1159/000215567, PubMed 3609912

Falch JA, Odegaard OR, Finnanger AM, Matheson I (1987)
Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecalciferol
Acta Med Scand, 221 (2), 199-204
DOI 10.1111/j.0954-6820.1987.tb01267.x, PubMed 3035879

Kittang E, Odegaard OR, Michalsen H (1986)
Cystic fibrosis: protease activity in saliva evaluated with chromogenic substrates
Eur J Respir Dis, 68 (4), 263-6
PubMed 3525206

Jacobsen D, Frederichsen PS, Knutsen KM, Sørum Y, Talseth T, Odegaard OR (1986)
Self-poisoning and moon phases in Oslo
Hum Toxicol, 5 (1), 51-2
DOI 10.1177/096032718600500110, PubMed 3949368

Odegaard OR, Røkke KE, Kjørstad H (1985)
[The geriatric outpatient team. Experiences from a year's activity in the Aker section, Oslo]
Tidsskr Nor Laegeforen, 105 (17-18), 1242-4
PubMed 4012733

Jacobsen D, Frederichsen PS, Knutsen KM, Sørum Y, Talseth T, Odegaard OR (1984)
Clinical course in acute self-poisonings: a prospective study of 1125 consecutively hospitalised adults
Hum Toxicol, 3 (2), 107-16
DOI 10.1177/096032718400300204, PubMed 6724591

Jacobsen D, Frederichsen PS, Knutsen KM, Sørum Y, Talseth T, Odegaard OR (1984)
A prospective study of 1212 cases of acute poisoning: general epidemiology
Hum Toxicol, 3 (2), 93-106
DOI 10.1177/096032718400300203, PubMed 6724595

Abildgaard U, Odegaard OR (1983)
[Antithrombin deficiency. Diagnosis and treatment]
Tidsskr Nor Laegeforen, 103 (1), 18-20
PubMed 6845291

Anker E, Odegaard OR, Raknerud N (1982)
[Primary pulmonary hypertension]
Tidsskr Nor Laegeforen, 102 (32), 1712-5
PubMed 7167943

Odegaard OR, Okkenhaug M, Pedersen J (1982)
[Body temperature, how should it be measured?]
Tidsskr Nor Laegeforen, 102 (22), 1062-4
PubMed 7164058

Berdal BP, Hushovd O, Olsvik O, odegård OR, Bergan T (1982)
Demonstration of extracellular proteolytic enzymes from Legionella species strains by using synthetic chromogenic peptide substrates
Acta Pathol Microbiol Immunol Scand B, 90 (2), 119-23
DOI 10.1111/j.1699-0463.1982.tb00092.x, PubMed 7044037

Odegaard OR (1981)
[Amoxicillin (Imacillin) induced exanthema. What happens during the continued use?]
Tidsskr Nor Laegeforen, 101 (34-36), 1973
PubMed 7339990

Odegård OR, Abildgaard U (1978)
Antithrombin III: critical review of assay methods. Significance of variations in health and disease
Haemostasis, 7 (2-3), 127-34
DOI 10.1159/000214249, PubMed 350729

Odegård OR, Lie M (1978)
On use of chromogenic substrates for studies of coagulation inhibitors
Haemostasis, 7 (2-3), 121-6
DOI 10.1159/000214248, PubMed 658774

Odegård OR, Rosenlund B, Ervik E (1978)
Automated antithrombin III assay with a centrifugal analyser
Haemostasis, 7 (4), 202-9
DOI 10.1159/000214262, PubMed 658785

Odegård OR, Abildgaard U, Lie M, Miller-Andersson M (1977)
Inactivation of bovine and human thrombin and factor Xa by antithrombin III studied with amidolytic methods
Thromb Res, 11 (2), 205-61
DOI 10.1016/0049-3848(77)90039-1, PubMed 905972

Odegård OR, Abildgaard U (1977)
Antifactor Xa activity in thrombophilia. Studies in a family with Ar-III deficiency
Scand J Haematol, 18 (2), 86-90
DOI 10.1111/j.1600-0609.1977.tb02076.x, PubMed 841273

Odegärd OR, Fagerhol MK, Lie M (1976)
Heparin cofactor activity and antithrombin III concentration in plasma related to age and sex
Scand J Haematol, 17 (4), 258-62
DOI 10.1111/j.1600-0609.1976.tb01183.x, PubMed 63141

Odegård OR, Teien AN (1976)
Antithrombin III, heparin cofactor and antifactor Xa in a clinical material
Thromb Res, 8 (2), 173-8
DOI 10.1016/0049-3848(76)90260-7, PubMed 56054

Odegård OR, Lie M, Abildgaard U (1976)
Antifactor Xa activity measured with amidolytic methods
Haemostasis, 5 (5), 265-75
DOI 10.1159/000214145, PubMed 1017722

Abildaard U, Lie M, Odegård OR (1976)
A simple amidolytic method for the determination of functional active antithrombin III
Scand J Clin Lab Invest, 36 (1), 109-12
DOI 10.1080/00365517609068026, PubMed 815998

Odegård OR, Abildgaard U (1975)
Proceedings: Coagulation inhibitors in plasma and serum
Thromb Diath Haemorrh, 34 (1), 346
PubMed 1188790

Abildgaard U, Lie M, Teien A, Odegård OR (1975)
Proceedings: Coagulation inhibitors studied with chromogenic substrate
Thromb Diath Haemorrh, 34 (1), 345
PubMed 1188787

Odegård OR (1975)
Evaluation of an amidolytic heparin cofactor assay method
Thromb Res, 7 (2), 351-60
DOI 10.1016/0049-3848(75)90193-0, PubMed 51519

Odegard OR, Lie M, Abildgaard U (1975)
Heparin cofactor activity measured with an amidolytic method
Thromb Res, 6 (4), 287-94
DOI 10.1016/0049-3848(75)90078-x, PubMed 49087

Abildgaard U, Odegård OR, Kierulf P, Pepper DS (1974)
Influence of platelet factor 4 on inhibited thrombin substrate reactions
Thromb Res, 5 (2), 185-96
DOI 10.1016/0049-3848(74)90067-x, PubMed 4472150

Odegaard OR, Gleditsch E (1970)
The diagnostic value of coeliacography
Scand J Gastroenterol Suppl, 7, 163-4
PubMed 5271838

Other articles

Abdulkadir J, Feleke Y, Berg JP, Falch JA, Odegaard OR (1997)
Absence of the factor V Leiden mutation in Ethiopians
Thromb Res, 86 (5), 431-2
DOI 10.1016/s0049-3848(97)00090-x, PubMed 9211636

Odegaard OR (1993)
[Physicians' practice in declaring the patients fit]
Tidsskr Nor Laegeforen, 113 (2), 231
PubMed 8430410

Odegaard OR, Try K, Abildgaard U (1986)
Protein C: a simplified semi-automated activity assay
Thromb Res, 42 (2), 257-62
DOI 10.1016/0049-3848(86)90301-4, PubMed 3754988

Abildgaard U, Andersson TR, Try K, Odegaard OR (1986)
[Contraceptive agents and antithrombin III. New causes of thrombosis]
Tidsskr Nor Laegeforen, 106 (4), 346-7
PubMed 3961755

Odegård OR, Lie M (1978)
Simultaneous inactivation of thrombin and factor Xa by AT-III: influence of heparin
Thromb Res, 12 (4), 697-700
DOI 10.1016/0049-3848(78)90261-x, PubMed 663903

Abildgaard U, Lie M, Odegård OR (1977)
Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH)
Thromb Res, 11 (4), 549-53
DOI 10.1016/0049-3848(77)90208-0, PubMed 72424

Book chapters

Andersen MS, Abildgaard U, Liestøl S, Sandset PM, Mowinckel MC, Ødegaard OR, Larsen ML, Diep LM (2004)
The ability of three global plasma assays to recognize thrombophilia
In Thrombosis research, Pergamon Press, New York, 113(2004)6, S. 411-17
BIBSYS 051896508

Lindahl TL, Egeberg N, Hillarp A, Ødegaard OR, Edlund B, Svensson J, Sandset PM, Rånby M (2004)
INR calibration of owren-type prothombrin time based on the relationship between PT\% and INR utilizing normal plasma samples
In Thrombosis and haemostasis, Schattauer, Stuttgart, 91(2004)6, S. 1223-1231
BIBSYS 051926776

Dahl T, Kontny F, Slagsvold CE, Christophersen B, Abildgaard U, Ødegaard OR, Mørkrid L, Dale J (2000)
Lipoprotein(a), other lipoproteins and hemostatic profiles in patients with ischemic stroke: the relation to cardiogenic embolism
In Cerebrovascular diseases, Karger, Basel ; New York, 10(2000)nr 2, S.110-117
BIBSYS 010641017